News & Events
May 1, 2018 |
Sebela Pharmaceuticals Acquires Braintree Laboratories |
January, 2013 |
Approval of Suclear® (sodium sulfate, potassium sulfate and magnesium sulfate oral solution; PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution) |
June, 2011 |
Braintree awarded the Premier Pinnacle Award |
August, 2010 |
Approval of SUPREP® BOWEL PREP KIT (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution (17.5g/3.13g/1.6g) per 6 ounces |
July, 2010 |
Approval of 5 mg HalfLytely® and Bisacodyl Tablet Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablet) With Flavor Packs |
October, 2009 |
Braintree Laboratories, Inc and Ipsen: Ipsen acquires exclusive marketing rights of BLI-800 from Braintree Laboratories, Inc for colonic cleansing before colonoscopy |
September, 2007 |
Approval of 10 mg HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets) With Flavor Packs |
October, 2006 |
MiraLAX® (Polyethylene Glycol 3350, NF Powder) OTC approved 1 |
June, 2005 |
Braintree Laboratories, Inc. announces the acquisition of Axid® (nizatidine) Oral Solution from Reliant Pharmaceuticals2 |
May, 2004 |
Approval of HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets) With Flavor Packs |
August, 2003 |
Braintree Laboratories, Inc completed transition of the product PhosLo® (Calcium Acetate) to Nabi Biopharmaceuticals3 |
June, 2003 |
Approval of NuLYTELY® (PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution) With Flavor Packs |
December, 2001 |
Braintree Laboratories, Inc and its employees present the firefighters of New York City with a brand new state-of-the-art Seagrave Tower Ladder Truck – FDNY Ladder Co. 107 |
April, 2001 |
Approval of PhosLo® GelCaps (Calcium Acetate) 667 mg |
February, 1999 |
Approval of MiraLax® (Polyethylene Glycol 3350, NF Powder) |
April, 1991 |
Approval of NuLYTELY® (PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution) |
December, 1990 |
Approval of PhosLo® (Calcium Acetate tablets) 667mg 3 |
July, 1984 |
Approval of the first oral lavage solution, GoLYTELY® (PEG-3350 and Electrolytes for Oral Solution) |
|